China & United States — Social Security Administration

China: Regulatory progress; BLA accepted and designated for priority review.

United States — Social Security Administration: Included Leqembi in Commercial Insurance Innovative Drug List, facilitating access in China.

China: China market had a stockpiling effect in Q2 2025; Leqembi included in Commercial Insurance Innovative Drug List in Dec 2025, supporting future sales.

United States — Social Security Administration: NHSA included Leqembi in Commercial Insurance Innovative Drug List in Dec 2025, aiding market access in China.

China: China>>> is among the countries that would face a 12.5% additional tariff due to alleged forced labor imports.

United States — Social Security Administration: Frank Bisignano>>> is splitting his duties between the United States — Internal Revenue Service and the United States — Social Security Administration>>>, highlighting a potential conflict of interest or overextension of responsibilities.

United States — Social Security Administration: The United States — Social Security Administration would receive over $3.5 billion in increased funds to develop and modernize warheads and naval technology under the proposed budget.

United States — Social Security Administration: The United States — Social Security Administration is a co-host of the China Medical Insurance Imaging AI Recognition Competition, playing a key role in its organization and promotion.